Using Biomarkers for Precision in Cardiovascular Medicine, Prevention and Population Health
Houston Methodist DeBakey CV Education via YouTube
Overview
Explore a comprehensive grand rounds presentation examining the transition to precision medicine in cardiology through the lens of biomarkers and risk assessment. Learn how to evaluate cardiovascular risk assessment approaches using biomarkers like c-reactive protein, troponins, and natriuretic peptides, while understanding their strengths and limitations. Master the application of actuarial risk assessment for specific cardiovascular outcomes to guide prevention and treatment decisions. Discover strategies for incorporating risk assessment into population health initiatives for cardiovascular prevention, presented by Dr. James de Lemos, Chief of Cardiology at UT Southwestern, as he discusses whether biomarkers can truly add precision to cardiovascular medicine, prevention, and population health.
Syllabus
Using Biomarkers for Precision to CV Medicine, Prevention and Population Health (James de Lemos, MD)
Taught by
Houston Methodist DeBakey CV Education